These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36891704)

  • 1. [Meta-analysis of β-blockers for the primary prevention of liver cirrhosis with clinically significant portal hypertension with no or small esophageal varices].
    Su X; Li WJ; Chen Z; Wu QB; Yin MH; Han X; Zhang DP; Zhou XQ; Zhu H
    Zhonghua Gan Zang Bing Za Zhi; 2022 Nov; 30(11):1237-1245. PubMed ID: 36891704
    [No Abstract]   [Full Text] [Related]  

  • 2. Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices.
    Zacharias AP; Jeyaraj R; Hobolth L; Bendtsen F; Gluud LL; Morgan MY
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD011510. PubMed ID: 30372514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonselective beta-blockers in cirrhotic patients with no or small varices: A meta-analysis.
    Qi XS; Bao YX; Bai M; Xu WD; Dai JN; Guo XZ
    World J Gastroenterol; 2015 Mar; 21(10):3100-8. PubMed ID: 25780311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Band ligation versus no intervention for primary prevention of upper gastrointestinal bleeding in adults with cirrhosis and oesophageal varices.
    Vadera S; Yong CWK; Gluud LL; Morgan MY
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012673. PubMed ID: 31220333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis.
    Roccarina D; Best LM; Freeman SC; Roberts D; Cooper NJ; Sutton AJ; Benmassaoud A; Plaz Torres MC; Iogna Prat L; Csenar M; Arunan S; Begum T; Milne EJ; Tapp M; Pavlov CS; Davidson BR; Tsochatzis E; Williams NR; Gurusamy KS
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013121. PubMed ID: 33822357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: controversies surrounding the use of carvedilol and other beta blockers in the management of portal hypertension and cirrhosis.
    Gillespie SL; Hanrahan TP; Rockey DC; Majumdar A; Hayes PC
    Aliment Pharmacol Ther; 2023 Mar; 57(5):454-463. PubMed ID: 36691947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of oesophageal varices: study protocol for a randomised controlled trial.
    Patel VC; McPhail MJ; Uddin R; Jafari H; Lawrence V; Le Boutillier C; Shearer J; Yaziji N; Cape A; Ahmed H; Ward C; Walsh P; Besly K; Zamalloa A; Kelly J; ; Carter B
    Trials; 2024 Apr; 25(1):265. PubMed ID: 38627804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis.
    Plaz Torres MC; Best LM; Freeman SC; Roberts D; Cooper NJ; Sutton AJ; Roccarina D; Benmassaoud A; Iogna Prat L; Williams NR; Csenar M; Fritche D; Begum T; Arunan S; Tapp M; Milne EJ; Pavlov CS; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013122. PubMed ID: 33784794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices.
    Paternostro R; Becker J; Hofer BS; Panagl V; Schiffke H; Simbrunner B; Semmler G; Schwabl P; Scheiner B; Bucsics T; Bauer D; Binter T; Trauner M; Mandorfer M; Reiberger T
    Dig Liver Dis; 2022 Apr; 54(4):500-508. PubMed ID: 34799282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Therapies for Primary Prevention of Esophageal Variceal Bleeding: A Systematic Review and Network Meta-analysis.
    Sharma M; Singh S; Desai V; Shah VH; Kamath PS; Murad MH; Simonetto DA
    Hepatology; 2019 Apr; 69(4):1657-1675. PubMed ID: 30125369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sclerotherapy versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.
    Gattini D; Cifuentes LI; Torres-Robles R; Gana JC
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD011573. PubMed ID: 32133620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of ß-blocker therapy to prevent primary bleeding of esophageal varices.
    Tursi T
    J Am Acad Nurse Pract; 2010 Dec; 22(12):640-7. PubMed ID: 21129071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blockers for prophylaxis of bleeding from esophageal varices in cirrhotic portal hypertension. Review of the literature.
    Zoller WG; Gross M
    Eur J Med Res; 1996 Jun; 1(9):407-16. PubMed ID: 9353240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary prevention of bleeding from esophageal varices in patients with liver cirrhosis: An update and review of the literature.
    Garbuzenko DV; Arefyev NO
    J Evid Based Med; 2020 Nov; 13(4):313-324. PubMed ID: 33037792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis.
    Villanueva C; Torres F; Sarin SK; Shah HA; Tripathi D; Brujats A; Rodrigues SG; Bhardwaj A; Azam Z; Hayes PC; Jindal A; Abid S; Alvarado E; Bosch J;
    J Hepatol; 2022 Oct; 77(4):1014-1025. PubMed ID: 35661713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined therapies versus monotherapies for the first variceal bleeding in patients with high-risk varices: a meta-analysis of randomized controlled trials.
    Bai M; Qi X; Yang M; Han G; Fan D
    J Gastroenterol Hepatol; 2014 Mar; 29(3):442-52. PubMed ID: 24118091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing the development of varices in cirrhosis.
    Garcia-Tsao G
    J Clin Gastroenterol; 2007; 41 Suppl 3():S300-4. PubMed ID: 17975480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blockers versus placebo or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.
    Cifuentes LI; Gattini D; Torres-Robles R; Gana JC
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD011973. PubMed ID: 33498095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis.
    Cifuentes LI; Gattini D; Torres-Robles R; Gana JC
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD011561. PubMed ID: 33522602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults.
    Gluud LL; Krag A
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD004544. PubMed ID: 22895942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.